Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Grujic Alan 2. Issuer Name and Ticker or Trading Symbol GUIDED THERAPEUTICS INC [GTHP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 5835 PEACHTREE CORNERS EAST, SUITE B 3. Date of Earliest Transaction (Month/Day/Year) 08/21-05:00/2025 (Street) PEACHTREE CORNERS, GA 30092 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/21-05:00/2025 J(1) 17,408 A (1) 1,465,433 D Preferred Series E Stock 08/21-05:00/2025 J(2) 50 D (2) 0 D Common Stock 08/21-05:00/2025 J(2) 200,000 A (2) 1,665,433 D Common Stock 08/29-05:00/2025 P(3) 152,108 A (3) 1,817,541 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrants

$0.25

08/29-05:00/2025

P(3)

152,108

08/29-05:00/2025

08/28-05:00/2029

Common Stock

152,108

(3)

177,108

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Grujic Alan 5835 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS, GA 30092	X

Signatures

/s/ Alan Grujic		09/04-05:00/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298.
(2)	On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.
(3)	On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.